340B Drug Pricing Program Oversight and Administration
House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations Testimony on 340B Drug Pricing Program Oversight and Administration
Dec. 15, 2005, 1:15 p.m.
Stuart Wright, Deputy Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services